MENU
+Compare
ANIX
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$3.08
Change
-$0.09 (-2.84%)
Capitalization
99.17M

ANIX Anixa Biosciences Forecast, Technical & Fundamental Analysis

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANIX with price predictions
Feb 21, 2025

ANIX's RSI Indicator ascending out of oversold territory

The RSI Oscillator for ANIX moved out of oversold territory on January 15, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In of the 19 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ANIX moved above its 50-day moving average on January 28, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ANIX crossed bullishly above the 50-day moving average on January 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIX advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where ANIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 46 cases where ANIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on February 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANIX as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANIX turned negative on February 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANIX broke above its upper Bollinger Band on January 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.958) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). ANIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (384.615) is also within normal values, averaging (251.221).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANIX is expected to report earnings to fall 21.36% to -8 cents per share on March 14

Anixa Biosciences ANIX Stock Earnings Reports
Q1'25
Est.
$-0.09
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.10
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.01
The last earnings report on January 01 showed earnings per share of -10 cents, missing the estimate of -8 cents. With 112.37K shares outstanding, the current market capitalization sits at 99.17M.
A.I. Advisor
published General Information

General Information

a developer of non-invasive blood tests for the early detection of solid tumor based cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Computer Peripherals
Address
3150 Almaden Expressway
Phone
+1 408 708-9808
Employees
5
Web
https://www.anixa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRMD0.14N/A
+2.27%
MariMed Inc.
SSDOY17.930.13
+0.73%
Shiseido Company, Ltd.
SQZB0.03N/A
N/A
SQZ Biotechnologies Company
GOFPY8.95-0.13
-1.40%
Greek Organisation of Football Prognostics SA
UMGNF29.33-0.45
-1.51%
UNIVERSAL MUSIC GROUP

ANIX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GERN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-2.84%
GERN - ANIX
34%
Loosely correlated
-2.28%
RYTM - ANIX
29%
Poorly correlated
-2.89%
CDTX - ANIX
27%
Poorly correlated
-3.75%
DNLI - ANIX
27%
Poorly correlated
-3.98%
PRTA - ANIX
27%
Poorly correlated
+2.03%
More